Browse EV MemProt Atlas
- Frequency:
- literature support frequency.
- EVMP score:
annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| DP13A | Q9UKG1 | DCC-interacting protein 13-alpha (Dip13-alpha) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 1) | Disease related genesHuman disease related genesPredicted intracellular proteins | Fusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.50 | ||||
| DRD1 | P21728 | D(1A) dopamine receptor (Dopamine D1 receptor) | 7 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| DRP2 | Q13474 | Dystrophin-related protein 2 (DRP-2) | Other mediation | 1 | 0.50 | |||||
| DSEL | Q8IZU8 | Dermatan-sulfate epimerase-like protein (EC 5.1.-.-) | 2 | Metabolism mediation | 1 | 0.50 | ||||
| DVL1 | O14640 | Segment polarity protein dishevelled homolog DVL-1 (Dishevelled-1) (DSH homolog 1) | Disease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| E41L3 | Q9Y2J2 | Band 4.1-like protein 3 (4.1B) (Differentially expressed in adenocarcinoma of the lung protein 1) (DAL-1) (Erythrocyte membrane protein band 4.1-like 3) [Cleaved into: Band 4.1-like protein 3, N-terminally processed] | Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins | Fusion and delivery mediation | 1 | 0.50 | ||||
| EFR3A | Q14156 | Protein EFR3 homolog A (Protein EFR3-like) | Disease related genesPredicted intracellular proteins | Metabolism mediation | 1 | 0.50 | ||||
| EFR3B | Q9Y2G0 | Protein EFR3 homolog B | Predicted intracellular proteins | Metabolism mediation | 1 | 0.50 | ||||
| EGFR | P00533 | Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) | Cancer-related genesDisease related genesEnzymesFDA approved drug targetsHuman disease related genesMetabolic proteinsPlasma proteinsPredicted membrane proteinsPredicted secreted proteinsRAS pathway related proteinsTransporters | 1 | Angina pectorisBrain cancerBreast cancerCerebral ischaemiaChronic painColon cancerColorectal cancerCryptosporidiosisDiabetic foot ulcerDiffuse large B-cell lymphomaDigestive system diseaseEsophageal cancerGram-positive bacterial infectionHead and neck cancerHepatitis virus infectionHypopharyngeal cancerIntracerebral haemorrhageIschemiaLiver cancerLung cancerLymphomaMalignant mesenchymal neoplasmMature B-cell leukaemiaMelanomaMetastatic biliary tract neoplasmsMetastatic lymph node neoplasmMyelodysplastic syndromeNasopharyngeal cancerNon-small-cell lung cancerPancreatic cancerPsoriasisRenal cell carcinomaSkin postprocedural disorderSolid tumour/cancerSpinal cord/cranial nerve neoplasmStomach cancerTesticular cancerUnspecific body region injuryUrethral cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | ||
| EGLN | P17813 | Endoglin (CD antigen CD105) | Cancer-related genesCandidate cardiovascular disease genesCD markersDisease related genesHuman disease related genesPlasma proteinsPredicted membrane proteins | 1 | AngiosarcomaBrain cancerBreast cancerFallopian tube cancerGynecologic cancerKaposi sarcomaLiver cancerLung cancerNon-small-cell lung cancerOvarian cancerPeritoneal cancerRenal cell carcinomaRetinopathy | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | ||
| EHD3 | Q9NZN3 | EH domain-containing protein 3 (PAST homolog 3) | Plasma proteinsPredicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||||
| ELAP1 | Q6UXG2 | Endosome/lysosome-associated apoptosis and autophagy regulator 1 (Estrogen-induced gene 121 protein) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Fusion and delivery mediation | 1 | 0.50 | |||
| ENOX1 | Q8TC92 | Ecto-NOX disulfide-thiol exchanger 1 (Candidate growth-related and time keeping constitutive hydroquinone [NADH] oxidase) (cCNOX) (Cell proliferation-inducing gene 38 protein) (Constitutive Ecto-NOX) (cNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)] | Predicted intracellular proteins | Fusion and delivery mediation | 1 | 0.50 | ||||
| ENTK | P98073 | Enteropeptidase (EC 3.4.21.9) (Enterokinase) (Serine protease 7) (Transmembrane protease serine 15) [Cleaved into: Enteropeptidase non-catalytic heavy chain; Enteropeptidase catalytic light chain] | Disease related genesEnzymesHuman disease related genesPotential drug targetsPredicted intracellular proteins | 1 | Clinical-translation mediation | 1 | 0.50 | |||
| EPHA2 | P29317 | Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK) | 1 | Brain cancerSolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | |||
| EPHA3 | P29320 | Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1) | Cancer-related genesDisease related genesEnzymesPotential drug targetsPredicted intracellular proteinsPredicted membrane proteins | 1 | Acute myeloid leukaemiaBrain cancerMalignant haematopoietic neoplasmMyelodysplastic syndrome | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | ||
| EQTN | Q9NQ60 | Equatorin (Acrosome formation-associated factor) | Predicted membrane proteinsPredicted secreted proteins | 1 | Fusion and delivery mediation | 1 | 0.50 | |||
| ERBIN | Q96RT1 | Erbin (Densin-180-like protein) (Erbb2-interacting protein) (Protein LAP2) | Predicted intracellular proteins | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| EVI2A | P22794 | Protein EVI2A (Ecotropic viral integration site 2A protein homolog) (EVI-2A) | Predicted membrane proteins | 1 | Other mediation | 1 | 0.50 | |||
| EVI2B | P34910 | Protein EVI2B (Ecotropic viral integration site 2B protein homolog) (EVI-2B) (CD antigen CD361) | CD markersPredicted membrane proteins | 1 | Immune mediation | 1 | 0.50 | |||
| FAK2 | Q14289 | Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK) | Disease related genesEnzymesPlasma proteinsPotential drug targetsPredicted intracellular proteins | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| FBSP1 | P0C2W1 | F-box/SPRY domain-containing protein 1 (F-box only protein 45) (hFbxo45) | Predicted intracellular proteinsPredicted secreted proteins | Fusion and delivery mediation | 1 | 0.50 | ||||
| FBXL2 | Q9UKC9 | F-box/LRR-repeat protein 2 (F-box and leucine-rich repeat protein 2) (F-box protein FBL2/FBL3) | Predicted intracellular proteins | Immune mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| FCG2A | P12318 | Low affinity immunoglobulin gamma Fc region receptor II-a (IgG Fc receptor II-a) (CDw32) (Fc-gamma RII-a) (Fc-gamma-RIIa) (FcRII-a) (CD antigen CD32) | CD markersFDA approved drug targetsHuman disease related genesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteins | 1 | Chronic kidney diseaseLupus erythematosusThrombocytopenia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||
| FGD1 | P98174 | FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) | Disease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteins | Receptor-signaling mediation | 1 | 0.50 |